FDA granted Fast Track designation to AMX0114, a treatment related to Amylyx Pharmaceuticals' mission.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Amylyx Pharmaceuticals →

  American biopharmaceutical company

  Nothing else this week.

Related events

• FDA granted Fast Track designation to NRX-100 on September 4, 2025.Jun 7
• Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.Aug 18
• FDA granted Fast Track Designation to a Nuvation drug, while Jim Cramer shared stock opinions on CNBC.Sep 6
• Avexitide received FDA Breakthrough Therapy designation.Jun 8